Natural Products in Neurodegenerative Diseases: Current Trends and Future Perspectives

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cells of the Nervous System".

Deadline for manuscript submissions: 30 June 2025 | Viewed by 5177

Special Issue Editors


E-Mail Website
Guest Editor
Department of Pharmacology, National and Kapodistrian, University of Athens, Athens, Greece
Interests: metabolic studies; protein–ligand interactions; protein aggregation processes in AD; metabolomics
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
First Department of Psychiatry, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Interests: psychopharmacology; sex differences; antidepressants

Special Issue Information

Dear Colleagues,

The continuing demographic transition toward an aging society is leading to the growing prevalence of chronic age-related diseases. This is extremely important due to the lack of effective treatment and associated immense socioeconomic burden on all industrialized countries. Neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) are persistent progressive diseases associated with an abnormal accumulation and aggregation of disease-specific proteins and peptides. Such changes have been linked to a noticeable activation of immune responses, increased levels of oxidative stress and neuronal cell death. Even though there has been tremendous knowledge growth into the disease mechanisms of neurodegenerative disorders, there is a great need for developing effective disease-modifying agents. Medicinal plants have been used for their “anti-aging” and cognitive enhancing properties. In view of a suggested mechanistic link between oxidative stress, inflammation and neurodegeneration, plant-derived neuroprotective compounds and dietary antioxidants may offer a promising therapeutic route for modifying the progression or protecting against the risk of neurodegenerative diseases.

Prof. Dr. Anthony Tsarbopoulos
Dr. Nikolaos Kokras
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • bioactive compounds
  • protein aggregation processes in AD
  • cognitive, anxiolytic and antidepressant effects

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

22 pages, 3953 KiB  
Article
Flaxseed Oil Alleviates Trimethyltin-Induced Cell Injury and Inhibits the Pro-Inflammatory Activation of Astrocytes in the Hippocampus of Female Rats
by Nataša Mitrović, Marija Adžić Bukvić, Marina Zarić Kontić, Milorad Dragić, Snježana Petrović, Marija Paunović, Vesna Vučić and Ivana Grković
Cells 2024, 13(14), 1184; https://doi.org/10.3390/cells13141184 - 11 Jul 2024
Viewed by 979
Abstract
Exposure to the neurotoxin trimethyltin (TMT) selectively induces hippocampal neuronal injury and astrocyte activation accompanied with resultant neuroinflammation, which causes severe behavioral, cognitive, and memory impairment. A large body of evidence suggests that flaxseed oil (FSO), as one of the richest sources of [...] Read more.
Exposure to the neurotoxin trimethyltin (TMT) selectively induces hippocampal neuronal injury and astrocyte activation accompanied with resultant neuroinflammation, which causes severe behavioral, cognitive, and memory impairment. A large body of evidence suggests that flaxseed oil (FSO), as one of the richest sources of essential omega-3 fatty acids, i.e., α-linolenic acids (ALA), displays neuroprotective properties. Here, we report the preventive effects of dietary FSO treatment in a rat model of TMT intoxication. The administration of FSO (1 mL/kg, orally) before and over the course of TMT intoxication (a single dose, 8 mg/kg, i.p.) reduced hippocampal cell death, prevented the activation of astrocytes, and inhibited their polarization toward a pro-inflammatory/neurotoxic phenotype. The underlying protective mechanism was delineated through the selective upregulation of BDNF and PI3K/Akt and the suppression of ERK activation in the hippocampus. Pretreatment with FSO reduced cell death and efficiently suppressed the expression of inflammatory molecules. These beneficial effects were accompanied by an increased intrahippocampal content of n-3 fatty acids. In vitro, ALA pretreatment prevented the TMT-induced polarization of cultured astrocytes towards the pro-inflammatory spectrum. Together, these findings support the beneficial neuroprotective properties of FSO/ALA against TMT-induced neurodegeneration and accompanied inflammation and hint at a promising preventive use of FSO in hippocampal degeneration and dysfunction. Full article
Show Figures

Figure 1

12 pages, 2199 KiB  
Communication
Ergothioneine Prevents Neuronal Cell Death Caused by the Neurotoxin 6-Hydroxydopamine
by Saho Yuzawa, Motonari Nakashio, Suzuna Ichimura, Mikako Shimoda, Ayaka Nakashima, Yuka Marukawa-Hashimoto, Yusuke Kawano, Kengo Suzuki, Kenichi Yoshitomi, Masahiro Kawahara and Ken-ichiro Tanaka
Cells 2024, 13(3), 230; https://doi.org/10.3390/cells13030230 - 25 Jan 2024
Cited by 2 | Viewed by 3353
Abstract
Neuronal cell death is a key mechanism involved in the development and exacerbation of Parkinson’s disease (PD). The excessive production of reactive oxygen species (ROS) is a major cause leading to neuronal death; therefore, compounds that prevent oxidative stress-dependent neuronal death may be [...] Read more.
Neuronal cell death is a key mechanism involved in the development and exacerbation of Parkinson’s disease (PD). The excessive production of reactive oxygen species (ROS) is a major cause leading to neuronal death; therefore, compounds that prevent oxidative stress-dependent neuronal death may be promising as a preventive method for PD. Ergothioneine is a natural amino acid with antioxidant properties, and its protective functions in the body are attracting attention. However, there has been no investigation into the protective functions of ergothioneine using in vivo and in vitro PD models. Thus, in this study, we analyzed the efficacy of ergothioneine against 6-hydroxydopamine (6-OHDA)-dependent neuronal cell death using immortalized hypothalamic neurons (GT1-7 cells). First, we found that ergothioneine prevents 6-OHDA-dependent neuronal cell death by suppressing ROS overproduction in GT1-7 cells. The cytoprotective effect of ergothioneine was partially abolished by verapamil, an inhibitor of OCTN1, which is involved in ergothioneine uptake. Furthermore, ergothioneine-rich Rice-koji (Ergo-koji) showed cytoprotective and antioxidant effects similar to those of ergothioneine. Taken together, these results suggest that ergothioneine or foods containing ergothioneine may be an effective method for preventing the development and progression of PD. Full article
Show Figures

Figure 1

Back to TopTop